RAS

RMC-6291 View larger

RMC-6291

AT75131

CAS 2641998-63-0

More details

Molarity Calculation Cart®

HOW TO ORDER

$138.00

$138.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $62.10 Total: $6,210.00
150 $71.76 Total: $3,588.00
125 $84.18 Total: $2,104.50
110 $99.36 Total: $993.60
15 $117.30 Total: $586.50

Data sheet

Molecular FormulaC55H78FN9O8
Molecular Weight1012.26
CAS Numbers2641998-63-0
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeO=C(C#CC(N(C)C)(C)C)N1CCC(F)(C(=O)N(C)C(C(=O)NC2C(=O)N3NC(C(=O)OCC(C)(C)CC=4C5=CC(=CC=C5N(C4C=6C=CC=NC6C(OC)C)CC)N7CCOC(C7)C2)CCC3)C(C)C)CC1
ReferencesNichols R J, et al. RMC-6291, a next-generation tri-complex KRASG12C [ON] inhibitor, outperforms KRASG12C [OFF] inhibitors in preclinical models of KRASG12C cancers[J]. Cancer Research, 2022, 82[12_Supplement] 3595-3595.

More info

RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models [1].